though
muscl
subcutan
fat
tissu
consid
highli
immunogen
organ
current
vaccin
deliv
intramuscular
subcutan
inject
two
except
bacil
vaccin
tuberculosi
rabi
vaccin
develop
countri
appli
intraderm
insert
convent
hypoderm
needl
shallow
angl
skin
method
invent
mendel
mantoux
earli
success
vaccin
approach
time
lead
worldwid
erad
smallpox
perform
administ
vaccinia
viru
skin
use
bifurc
needl
due
increas
knowledg
impact
cutan
microenviron
innat
adapt
immun
respons
skin
recent
rediscov
attract
target
tissu
vaccin
also
immunotherapeut
approach
cancer
allergi
largest
organ
bodi
form
outermost
barrier
skin
provid
protect
physic
injuri
microorgan
toxin
solvent
deterg
ultraviolet
light
also
dehydr
depend
bodi
locat
skin
type
bodi
weight
hydrat
level
age
sex
ethnic
skin
properti
thick
vari
consider
jw
streilein
first
time
describ
skin
organ
arm
immun
surveil
function
coin
term
skinassoci
lymphoid
tissu
salt
soon
becam
clear
skinresid
cell
capabl
uptak
process
present
endogen
exogen
antigen
continu
migrat
drain
lymph
node
ln
blood
dissect
role
differ
skinassoci
cell
type
healthi
inflam
skin
uptod
concept
skin
immun
system
draft
skin
basic
consist
three
layer
epidermi
dermi
subcutan
fat
tissu
superfici
waterrepel
keratin
layer
epidermi
also
design
stratum
corneum
compos
rigid
diskshap
cell
polygon
outlin
known
corneocyt
dead
keratinocyt
tightli
bound
togeth
via
desmosom
embed
lamellar
structur
form
intercellular
lipid
cornifi
layer
act
almost
imperm
barrier
prevent
diffus
molecul
particularli
molecular
weight
beyond
da
hydrophil
properti
underneath
stratum
corneum
lay
viabl
epidermi
mainli
compos
keratinocyt
cell
migrat
outward
basal
membran
separ
epidermi
dermi
undergo
morpholog
biochem
chang
final
die
apoptosi
produc
horni
layer
second
absorpt
barrier
ion
size
select
variabl
tight
form
special
tight
junction
seal
intercellular
space
keratinocyt
past
decad
keratinocyt
turn
provid
innat
recognit
mechan
earli
inflamm
also
capabl
shape
adapt
immun
respons
inflammatori
stimuli
either
direct
interact
immun
cell
indirectli
influenc
cutan
dendrit
cell
dc
though
keratinocyt
unlik
potenti
prime
cell
steadi
state
might
abl
stimul
antigenexperienc
cell
certain
inflammatori
condit
activ
keratinocyt
involv
gener
adapt
immun
respons
via
releas
chemokin
cytokin
includ
gmcsf
thymic
stromal
lymphopoietin
tslp
shown
influenc
differenti
migrat
andor
polar
capac
dc
addit
keratinocyt
account
epiderm
cell
melanocyt
merkel
cell
langerhan
cell
lc
popul
epidermi
steadyst
condit
absenc
inflammatori
stimuli
lc
dc
present
epidermi
overal
lc
continu
migrat
skin
drain
ln
even
absenc
inflamm
therebi
monitor
cutan
environ
addit
dendrit
protrud
lc
penetr
tight
junction
collect
antigen
beyond
henc
lc
might
dc
access
antigen
superfici
epidermi
figur
presum
two
mechan
toler
selfantigen
cutan
bacteri
flora
maintain
peripher
dc
lc
capac
present
antigen
acquir
peripheri
well
memori
cell
migrat
region
ln
lc
cell
type
epidermi
express
ctype
lectin
langerin
mhc
class
ii
molecul
inflammationinduc
activ
caus
cross
basement
membran
epidermi
dermi
migrat
tcell
area
ln
dermal
layer
locat
underneath
epidermi
repres
contact
site
skin
bloodlymphat
system
ensur
exchang
cell
fluid
cell
resid
dermi
primarili
fibroblast
also
memori
cell
cell
mast
cell
natur
killer
cell
plasmacytoid
dc
differ
popul
dermal
dc
ddc
sessil
macrophag
found
layer
ddc
divid
langerin
langerinsubpopul
langerin
ddc
account
total
dc
popul
dermi
number
fluctuat
continu
recruit
blood
steadyst
well
inflammatori
condit
langerin
ddc
migrat
skindrain
ln
present
antigen
acquir
peripheri
notabl
lc
langerin
ddc
found
repres
distinct
dc
subset
base
ontogeni
ddc
made
ddc
divid
least
two
subset
base
presenc
absenc
express
langerin
ddc
demonstr
preferenti
migrat
ln
area
close
bcell
follicl
implic
cell
type
induct
humor
immun
respons
propos
cell
skin
make
almost
twice
number
cell
found
blood
differenti
cell
imprint
dc
stromal
cell
express
home
receptor
migrat
tissu
cognat
antigen
origin
deriv
mean
cell
first
encount
antigen
skin
drain
ln
express
skin
home
receptor
determin
subsequ
migrat
pattern
noninflam
skin
least
three
tlymphocyt
popul
distinguish
dendrit
epiderm
cell
detc
character
express
canon
cell
receptor
believ
recogn
selfpeptid
releas
keratinocyt
stress
condit
ii
dermal
cell
express
mix
panel
tcell
receptor
iii
recircul
cell
mainli
display
effector
memori
phenotyp
mast
cell
repres
anoth
immunocompet
cell
type
skin
effector
cutan
igemedi
immun
reaction
capac
express
releas
varieti
bioactiv
mediat
also
demonstr
promot
dc
matur
migrat
depend
context
also
exert
inhibitori
effect
subcutan
fat
tissu
also
known
hypodermi
skin
layer
mostli
target
deliveri
drug
vaccin
compos
fibroblast
adipocyt
link
dermi
collagen
fiber
white
fat
tissu
act
thermal
barrier
mechan
cushion
resid
immunocompet
cell
found
depend
bodi
site
skin
layer
variabl
vascular
allow
recruit
immun
cell
convent
subcutan
intramuscular
vaccin
perform
needl
reach
subcutan
fat
tissu
muscl
respect
larg
volum
vaccin
ml
administ
would
conveni
administr
dermi
intraderm
inject
furthermor
immunogen
subcutan
intramuscular
inject
depend
releas
inflammatori
molecul
due
tissu
damag
consequ
infiltr
leukocyt
attract
site
vaccin
instead
target
epiderm
dermal
profession
antigenpres
cell
standard
techniqu
intraderm
inject
term
mantoux
method
invent
charl
mantoux
tuberculin
test
kind
intraderm
inject
perform
insert
needl
angl
skin
deliveri
volum
avoid
either
enter
hypodermi
leakag
vaccin
due
superfici
inject
perform
techniqu
reli
welltrain
healthcar
personnel
moreov
intraderm
inject
describ
pain
compar
intramuscular
subcutan
inject
develop
local
erythema
edema
possibl
side
effect
due
presenc
lymph
vessel
dermi
intraderm
inject
lead
passiv
drainag
small
molecul
lymphat
system
wherea
larger
molecul
taken
activ
transport
drain
ln
activ
ddc
also
monocyt
neutrophil
attract
inflammatori
mediat
carri
vaccin
compon
drain
ln
enter
inject
site
bloodstream
recent
practic
impedi
associ
intraderm
inject
overcom
develop
novel
minim
noninvas
techniqu
includ
solid
coat
hollow
dissolv
micro
needl
mostli
group
array
circumvent
stratum
corneum
depend
needl
length
array
provid
deliveri
epiderm
dermal
compart
creat
transient
micropor
clinic
studi
vaccin
technolog
rate
less
pain
compar
mantoux
method
addit
advantag
might
possibl
selfadministr
patient
howev
also
limit
microneedlebas
immun
due
variabl
mechan
structur
properti
skin
microneedl
much
longer
though
theoret
thick
stratum
corneum
bypass
ii
choic
needl
length
might
crucial
immunolog
outcom
target
differ
skin
layer
result
activ
differ
immunocompet
skinresid
cell
iii
use
thin
microneedl
includ
risk
ruptur
skin
iv
amount
activ
compound
coat
onto
microneedl
limit
v
smaller
needl
diamet
restrict
use
carrier
liposom
nanoparticl
recent
develop
field
microneedlebas
vaccin
review
kim
et
al
besid
target
immunolog
suboptim
site
convent
needlebas
approach
potenti
lead
needlestick
injuri
well
intent
reus
respons
transmiss
bloodborn
diseas
hepat
hiv
henc
high
demand
needlefre
deliveri
technolog
regard
mass
vaccin
develop
countri
also
increas
complianc
especi
young
children
needlefre
method
enhanc
transcutan
antigen
deliveri
includ
liquid
jet
immun
epiderm
powder
immun
tape
strip
skin
abras
low
frequenc
ultrasound
thermoabl
novel
scan
laser
technolog
discuss
detail
review
provid
deliveri
platform
reproduc
time
highli
adapt
circumvent
stratum
corneum
earli
event
cutan
immun
respons
keratinocyt
react
epitheli
stress
product
variou
cytokin
chemokin
antimicrobi
peptid
express
differ
pattern
recognit
receptor
innat
immun
system
includ
tolllik
receptor
tlr
nucleotid
oligomer
domain
receptor
abl
recogn
pathogenassoci
molecular
pattern
pamp
lipopolysaccharid
peptidoglycan
flagellin
cpg
motif
dna
singlestrand
well
doublestrand
rna
product
cytokin
gmcsf
keratinocyt
provid
matur
migrat
signal
lc
dc
act
bridg
innat
adapt
immun
togeth
macrophag
recruit
blood
site
epitheli
damag
sampl
process
antigen
upon
activ
either
cytokin
deriv
epitheli
cell
sens
pamp
matur
migrat
drain
ln
present
antigen
cell
take
place
among
factor
result
type
immun
respons
shape
rout
antigen
entri
applic
antigen
barrierdisrupt
skin
discuss
prerequisit
allerg
sensit
candid
molecul
initi
respons
follow
epitheli
trauma
includ
tslp
releas
epitheli
cell
recent
work
shown
respons
barrier
disrupt
keratinocyt
upregul
mhclike
ligand
mice
mica
human
bind
activ
receptor
natur
killer
cell
lectinlik
receptor
intraepitheli
cell
eventu
induc
respons
concomitantli
acquir
antigen
figur
establish
word
epimmunom
umbrella
term
molecul
express
epitheli
cell
instruct
immun
cell
swami
recent
draft
concept
emphas
degre
barrier
disrupt
determin
induc
thelper
profil
accord
model
rel
mild
epitheli
stress
abras
result
domin
express
tslp
preferenti
trigger
respons
wherea
case
deep
epitheli
trauma
cell
induc
type
ifn
tnf
figur
target
differ
skin
layer
transcutan
immun
may
therefor
induc
appropri
immun
respons
type
specif
requir
scan
laser
technolog
repres
except
versatil
approach
skin
layer
specif
target
simpl
adjust
laser
set
therebi
creat
tailor
immun
respons
type
infrar
laser
use
variou
biomed
applic
control
ablat
precis
cut
organ
tissu
sinc
efficaci
base
fact
biolog
tissu
high
water
content
strongli
absorb
energi
infrar
rang
result
rapid
evapor
water
buildup
high
local
pressur
disrupt
cellular
network
expel
cellular
materi
site
laser
applic
ablat
efficaci
correl
amount
energi
appli
target
area
measur
energi
fluenc
fluenc
defin
laser
puls
energi
per
focal
spot
area
measur
joul
per
squar
centimet
long
puls
length
high
puls
repetit
rate
increas
ablat
rate
heat
built
ablat
process
dissip
ablat
zone
puls
howev
result
thermal
injuri
increas
microtherm
zone
around
ablat
area
unwant
effect
use
high
energi
puls
short
puls
durat
less
water
relax
time
use
minim
transfer
heat
surround
tissu
result
neglig
thermal
damag
practic
infrar
laser
ablat
affect
number
addit
paramet
materi
ablat
plume
plasma
format
front
target
scatter
adsorb
incom
laser
beam
mitig
deposit
energi
subsequ
puls
thu
reduc
ablat
efficaci
first
demonstr
control
remov
human
stratum
corneum
perform
jacqu
et
al
use
puls
argon
fluorid
arf
excim
laser
stepwis
ablat
stratum
corneum
human
skin
sampl
interestingli
mildest
ablat
protocol
result
highest
skin
permeabl
complet
ablat
stratum
corneum
induc
moder
enhanc
transepiderm
water
uptak
indic
high
fluenc
use
experi
led
extens
thermal
injuri
tissu
cauter
major
ablat
mechan
arf
excim
laser
suggest
phototherm
laser
use
transderm
deliveri
drug
qswitch
rubi
nd
yag
laser
laser
howev
studi
appli
high
low
molecular
weight
drug
macromolecul
lasertr
skin
util
puls
erb
yag
laser
emit
light
wavelength
nm
correspond
well
main
absorpt
peak
water
contrast
laser
less
heat
surround
tissu
induc
result
littl
microtherm
zone
around
applic
site
cold
ablat
compar
studi
rubi
erb
yag
laser
latter
induc
highest
increas
flux
across
mous
skin
earlier
studi
use
laser
larg
focal
spot
size
sever
millimet
novel
devic
appli
fraction
ablat
process
result
array
individu
micropor
intact
tissu
advantag
deeper
cell
layer
target
without
gener
ulcer
lesion
complet
wound
heal
achiev
within
sever
day
gener
two
approach
fraction
laser
ablat
establish
one
use
grid
split
laser
beam
multipl
smaller
microbeam
second
reli
scan
devic
target
laserbeam
predefin
pattern
gener
individu
micropor
latter
approach
versatil
allow
easi
adjust
number
pore
per
area
accord
individu
need
sever
studi
use
fraction
erb
yag
scan
laser
transderm
deliveri
macromolecul
andor
vaccin
includ
precis
laser
epiderm
system
pantec
biosolut
ruggel
liechtenstein
lutron
san
jose
ca
usa
fraction
laser
lumeni
inc
santa
clara
ca
usa
laser
solta
palo
alto
ca
usa
figur
show
histolog
analysi
micropor
mous
skin
gener
pleas
devic
recent
review
fraction
laserassist
drug
deliveri
discuss
transcutan
vaccin
via
lasergener
micropor
requir
applic
larg
molecular
weight
substanc
rang
sever
kda
small
protein
antigen
complex
nanomet
micromet
rang
liposom
nanoparticl
microparticl
viral
particl
studi
use
uncharg
molecul
dextran
polyethylen
glycol
confirm
permeat
rate
increas
number
micropor
per
area
decreas
increas
molecular
weight
compound
appli
fluenc
henc
pore
depth
littl
impact
appli
small
molecular
weight
drug
higher
fluenc
clearli
enhanc
uptak
larg
molecular
weight
drug
dextran
peptid
contrast
effect
fluenc
antigen
uptak
less
clear
respect
protein
chen
et
al
observ
littl
differ
uptak
ovalbumin
ova
appli
laserpor
skin
use
laser
energi
either
mj
increas
number
pore
show
clear
effect
contrast
saw
clear
depend
ova
uptak
subsequ
stimul
ovaspecif
tcell
respons
number
puls
per
pore
therebi
increas
fluenc
also
uptak
function
antibodi
proport
appli
fluenc
pore
number
recent
studi
four
test
protein
fitcbsa
show
enhanc
uptak
increas
fluenc
author
therefor
suggest
protein
antigen
uptak
direct
function
molecular
weight
appli
molecul
rather
determin
surfac
properti
protein
therefor
interact
local
microenviron
vaccin
studi
via
laserpor
skin
perform
mous
model
far
first
paper
demonstr
induct
antigenspecif
igg
antibodi
administr
protein
laserpor
skin
publish
lee
et
al
author
show
transderm
vaccin
lysozym
enhanc
laserpor
appli
higher
fluenc
result
increas
antibodi
use
ova
model
antigen
chen
et
al
demonstr
appli
antigen
diffus
adjac
tissu
taken
local
lc
ddc
howev
ova
also
found
drain
ln
within
h
suggest
passiv
antigen
transport
via
affer
lymphat
consequ
laserpor
group
show
significantli
enhanc
antibodi
respons
compar
nonpretr
tapestrip
anim
author
suggest
micropor
serv
antigen
depot
continu
suppli
immun
system
antigen
prolong
time
match
observ
micropor
skin
area
show
attach
antigen
surfac
pore
slowli
diffus
deeper
layer
even
day
residu
depot
clearli
visibl
figur
flow
cytometr
analysi
skin
drain
ln
h
applic
fitclabel
dextran
mw
kda
micropor
reveal
increas
number
dc
carri
fluoresc
label
increas
pore
depth
among
antigenposit
cell
cell
domin
laserpor
well
subcutan
immun
howev
wherea
subcutan
deliveri
antigen
led
predomin
uptak
dc
laserpor
also
induc
uptak
dc
dc
subset
known
effect
induct
tcell
activ
humor
immun
compar
subcutan
inject
laserpor
induc
significantli
higher
tcell
prolifer
adopt
transfer
ovaspecif
cell
equal
dose
although
certainli
appli
antigen
taken
via
micropor
compar
intraderm
inject
tcell
prolifer
follow
laserpor
equal
effici
select
ablat
langerin
cell
show
activ
ova
transgen
cell
partli
depend
presenc
langerin
cell
vitro
restimul
splenocyt
vaccin
recipi
mice
subsequ
cytokin
profil
show
cytokin
increas
pore
depth
notabl
gmcsf
involv
cell
differenti
display
strike
increas
compar
subcutan
inject
also
group
treat
laser
puls
find
match
wide
accept
hypothesi
superfici
epitheli
damag
favor
induct
deep
epi
dermal
trauma
result
induct
respons
howev
find
adopt
transfer
experi
use
transgen
cell
could
confirm
vaccin
anim
expand
cell
transcutan
immun
experi
clear
respons
high
ratio
induct
ige
lack
induct
could
measur
irrespect
puls
number
antigen
ova
phl
antigen
dose
cytokin
could
detect
equal
dose
grass
pollen
allergen
phl
p
appli
via
transcutan
rout
prove
immunogen
subcutan
inject
contrast
latter
induc
antigenspecif
ige
interestingli
laserassist
transcutan
deliveri
allergen
alreadi
employ
diagnost
patch
test
allerg
diseas
induct
ige
problemat
respect
applic
allergenspecif
immunotherapi
adjuvant
tlr
agonist
cpgodn
poli
ic
use
balanc
type
respons
test
agonist
cpgodn
prove
potent
regard
induct
cellular
respons
suppress
ige
subsequ
use
evalu
protect
transcutan
vaccin
approach
allerg
sensit
airway
hyperrespons
ahr
grass
pollen
allergen
phl
p
transcutan
applic
phl
p
togeth
success
prevent
induct
allergenspecif
ige
suppress
system
sensit
infiltr
eosinophil
lung
contrast
subcutan
transcutan
applic
phl
p
without
cpg
protect
effect
even
exacerb
allerg
phenotyp
figur
moreov
use
therapeut
experiment
schedul
treatment
presensit
anim
transcutan
vaccin
phl
p
togeth
significantli
reduc
specif
ige
level
eosinophil
infiltr
bronchoalveolar
lavag
fluid
balf
indic
techniqu
efficaci
method
painless
needlefre
transcutan
immunotherapi
tcit
treat
allerg
diseas
second
set
experi
mimick
gold
standard
treatment
type
allergi
subcutan
immunotherapi
scit
without
modul
compar
tcit
without
adjuvant
interestingli
tcit
without
adjuv
prove
effect
adjuv
approach
success
allevi
ahr
reduc
number
lunginfiltr
leukocyt
moreov
regard
unwant
side
effect
tcit
prove
superior
scit
contrast
scit
approach
tcit
induc
system
boost
cytokin
antibodi
figur
summari
vaccin
via
lasergener
micropor
turn
highli
promis
method
tcit
allerg
diseas
data
point
substanti
differ
transcutan
subcutan
immun
respect
immun
respons
polar
demonstr
import
statu
immun
system
ie
sensit
prior
vaccin
reflect
prophylact
versu
therapeut
set
regard
allergenspecif
immunotherapi
via
skin
recent
two
approach
test
anim
model
andor
clinic
studi
first
base
pretreat
skin
adhes
tape
strip
follow
applic
allergen
includ
patch
second
method
allergen
appli
intact
skin
cover
occlus
tape
h
lead
antigenuptak
due
macer
skin
besid
applic
recombin
protein
also
investig
administr
rna
dnabas
vaccin
erb
yag
lasergener
micropor
use
pleas
devic
applic
gene
vaccin
encod
report
gene
luciferas
lasergener
micropor
induc
express
detect
vivo
luminesc
imag
contrast
express
normal
level
measur
intraderm
inject
amount
nucleic
acid
consequ
lack
antigen
express
prolifer
cell
skin
drain
ln
could
detect
variou
time
point
follow
applic
plasmid
dna
laserpor
skin
also
system
immun
respons
humor
cellular
induc
unpublish
data
hypothes
complet
lack
immunogen
genet
immun
via
aqueou
micropor
caus
rapid
degrad
plasmid
dna
rna
skinderiv
cytoplasm
nucleas
releas
cell
damag
laserpor
process
contrast
intraderm
intramuscular
needl
inject
induc
less
cell
damag
tissu
nucleas
dilut
rel
larg
quantiti
inject
buffer
inject
dna
taken
cell
extracellular
degrad
within
cell
major
dna
releas
cytoplasm
transport
vesicl
nucleu
thu
protect
cytoplasm
proteas
laserpor
fraction
erb
yag
laser
may
therefor
adequ
method
gene
vaccin
least
nake
gene
vaccin
contrast
femtosecond
infrar
titanium
sapphir
laser
shown
increas
express
intens
durat
intramuscularli
inject
dna
vaccin
without
induc
tissu
damag
rather
introduc
micropor
skin
laser
focus
small
region
skin
specif
depth
presum
introduc
pore
individu
cell
therebi
enhanc
dna
uptak
also
result
increas
immunogen
intraderm
inject
dna
vaccin
induc
higher
antibodi
titer
secret
increas
antitumor
activ
compar
vaccin
without
laser
treatment
result
demonstr
laserfacilit
immun
needleinject
dna
vaccin
also
feasibl
approach
tissu
damag
concomit
releas
nucleas
intercellular
space
avoid
howev
present
seem
way
perform
real
transcutan
genet
immun
laserpor
approach
complet
differ
compar
describ
use
nondestruct
nm
green
laser
prior
intraderm
intramuscular
administr
vaccin
site
laser
illumin
contrast
abl
techniqu
aim
increas
permeat
respect
antigen
method
stimul
antigenpres
cell
show
increas
motil
traffick
drain
ln
irradi
preillumin
induc
enhanc
humor
well
cellular
immun
respons
ova
influenza
vaccin
author
specul
alter
dermal
tissu
environ
due
perfor
perilymphat
basement
membran
disarray
collagen
fiber
disrupt
interact
well
enhanc
express
costimulatori
molecul
dc
may
respons
adjuv
effect
laser
treatment
transderm
vaccin
via
fraction
lasergener
micropor
becom
one
recent
advanc
fastgrow
field
skin
vaccin
versatil
method
use
deliv
lowmolecular
weight
drug
via
skin
also
shown
abl
transport
recombin
protein
even
function
antibodi
deeper
skin
layer
subsequ
circul
depend
target
skin
layer
differ
immunolog
outcom
achiev
mous
model
target
recombin
antigen
epidermi
induc
typic
immun
respons
type
ige
antibodi
induc
absenc
adjuv
strike
contrast
subcutan
immun
amount
antigen
adjuvant
alum
indispens
ige
induct
howev
deliv
antigen
dermal
compart
via
deep
pore
induc
gmcsf
involv
cell
differenti
find
match
wide
accept
hypothesi
superfici
epitheli
damag
favor
induct
deep
epi
dermal
trauma
result
induct
respons
coapplic
tlr
agonist
especi
cpgodn
abl
suppress
respons
even
protect
allerg
sensit
notabl
experiment
setup
mimick
specif
immunotherapi
sit
establish
allerg
immun
respons
mous
model
allerg
asthma
transcutan
applic
allergen
without
adjuv
could
downregul
respons
supposedli
induct
regulatori
cell
fact
transcutan
applic
antigen
predominantli
trigger
respons
immun
system
treatment
lead
suppress
sensit
individu
clearli
indic
impact
immun
statu
outcom
skin
immun
underli
mechan
seemingli
paradox
skin
immun
respons
unknown
need
investig
vaccin
approach
infecti
diseas
via
skin
recent
gain
increas
interest
owe
grow
knowledg
skin
immunolog
need
immunogen
rout
reduc
vaccin
dose
increas
efficaci
elderli
immunocompromis
individu
fuel
develop
novel
deliveri
modal
variou
devic
intraderm
inject
well
transcutan
immun
major
advantag
anticip
tran
cutan
vaccin
includ
rich
target
tissu
antigenpres
cell
effici
drainag
region
ln
possibl
gener
mucos
immun
respons
increas
patient
complianc
especi
children
afraid
needl
inject
howev
wherea
studi
focus
gener
protect
antibodi
titer
identif
clinic
correl
protect
reduc
viru
titer
qualit
differ
skin
immun
reaction
compar
standard
subcutan
intramuscular
inject
larg
ignor
advent
new
transgen
model
begin
unravel
immunolog
mechan
skinbas
vaccin
factor
applic
depth
applic
area
associ
level
tissu
damag
result
releas
damageassoci
molecular
pattern
damp
shown
substanti
influenc
type
immun
respons
induc
contrast
barrier
disrupt
method
tape
strip
microneedl
easili
adapt
paramet
fraction
laser
system
allow
us
investig
underli
immunolog
mechan
knowledg
imper
ration
design
safe
success
vaccin
strategi
especi
respect
tcit
allergi
alreadi
investig
clinic
trial
research
becam
awar
import
understand
mechan
skin
immun
reaction
prophylact
well
therapeut
set
order
avoid
therapyinduc
side
effect
worst
case
new
sensit
therapeut
appli
allergen
select
suitabl
adjuv
induc
desir
type
immun
respons
therefor
major
topic
vaccin
via
lasergener
micropor
transcutan
vaccin
gener
applic
adjuv
often
hamper
unaccept
side
effect
human
convent
needl
vaccin
applic
immun
modul
may
less
critic
appli
via
transcutan
rout
less
adjuv
system
releas
compar
im
sc
inject
high
diffus
rate
larg
molecular
substanc
via
lasergener
micropor
addit
open
field
applic
complex
vaccin
formul
liposom
nanoparticl
microparticl
even
attenu
virus
viral
particl
hope
transcutan
vaccin
hold
true
laserpor
could
address
unmet
need
two
field
virus
enter
bodi
via
mucos
surfac
induct
mucos
antibodi
respons
therefor
import
mechan
induc
steril
protect
virus
hiv
sar
coronaviru
ii
sit
allerg
diseas
requir
subcutan
inject
suffer
unsatisfactori
efficaci
result
poor
patient
complianc
painless
applic
via
transcutan
vaccin
possibl
less
vaccin
therefor
highli
desir
goal
allergenspecif
immunotherapi
major
hurdl
commerci
laserbas
vaccin
approach
obvious
high
cost
associ
rel
complic
technolog
limit
use
special
equip
doctor
offic
although
laser
class
devic
selfadministr
home
privat
pantec
biosolut
current
develop
selfadministr
vaccin
gener
realist
option
especi
allergenspecif
immunotherapi
administ
close
medic
supervis
potenti
side
effect
associ
laserassist
transcutan
administr
also
transcutan
administr
method
gener
may
includ
local
temporari
hyperpigment
case
allergenspecif
immunotherapi
local
side
effect
itch
eczema
latter
may
requir
use
hypoallergen
allergoid
low
igebind
capac
one
technic
obstacl
high
variabl
skin
depend
age
ethnic
bodi
site
requir
special
effort
standard
pore
depth
address
issu
novel
fraction
laser
devic
continu
control
ablat
depth
real
time
current
develop
taken
togeth
laserpor
may
turn
highli
effici
method
painless
effect
transcutan
vaccin
gener
also
immunotherapeut
strategi
treat
allerg
diseas
one
remain
caveat
mous
data
avail
regard
immun
respons
induc
transcutan
laserassist
vaccin
first
clinic
trial
show
novel
approach
meet
expect
beyond
potenti
clinic
applic
defin
accur
reproduc
lasergener
micropor
skin
offer
sophist
versatil
highli
use
technolog
basic
scienc
investig
principl
mechan
skin
immun
